Literature DB >> 28693182

Location of the meso-pancreatoduodenum as a regional lymphatic basin for pancreatic head carcinoma.

Hirofumi Terakawa1, Hirohisa Kitagawa1, Isamu Makino1, Hironori Hayashi1, Katsunobu Oyama1, Hisatoshi Nakagawara1, Tomoharu Miyashita1, Hidehiro Tajima1, Hiroyuki Takamura1, Sachio Fushida1, Noriyuki Ozaki2, Tetsuo Ohta1.   

Abstract

The meso-pancreatoduodenum is the primary site of tumor infiltration in patients with pancreatic head cancer, with numerous patients exhibiting lymph node metastases. Effective dissection of the regional lymphatic basin requires knowledge of the patterns of the arterial branches. The present study examined the patterns of the arteries feeding the pancreatic head and the distribution of the meso-pancreatoduodenum. The present study included 123 patients with pancreatic cancer who underwent contrast-enhanced preoperative 64-multidetector-computed tomography to determine the routes of the inferior pancreaticoduodenal and first jejunal arteries. Surgical specimens and cadavers were also evaluated histologically to clarify the distribution of the meso-pancreatoduodenum. The feeding arteries were divided into three types, with 64.2% of patients having type A, 28.4% having type B and 7.3% having type C branches. The branches emerged from the back or left side of the superior mesenteric artery and ran to the far side of the pancreatic head in an arc. Consequently, the meso-pancreatoduodenum had a roll-shaped appearance, surrounding the trunk arteries and extending to the left side of the superior mesenteric artery. Dissecting the right and left sides of the superior mesenteric artery during lymphadenectomy could improve the effectiveness of resection.

Entities:  

Keywords:  64-multidetector-computed tomography; lymphatic vessel involvement; meso-pancreatoduodenum; pancreatic head carcinoma; regional lymphatic basin

Year:  2017        PMID: 28693182      PMCID: PMC5494852          DOI: 10.3892/ol.2017.6138

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  16 in total

1.  Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Y Kawabata; T Tanaka; T Nishi; H Monma; S Yano; Y Tajima
Journal:  Eur J Surg Oncol       Date:  2012-05-09       Impact factor: 4.424

2.  Pancreatoduodenectomy With Systematic Mesopancreas Dissection Using a Supracolic Anterior Artery-first Approach.

Authors:  Yosuke Inoue; Akio Saiura; Ryuji Yoshioka; Yoshihiro Ono; Michiro Takahashi; Junichi Arita; Yu Takahashi; Rintaro Koga
Journal:  Ann Surg       Date:  2015-12       Impact factor: 12.969

3.  CT diagnosis of recurrence after pancreatic cancer: is there a pattern?

Authors:  Tobias Heye; Nicola Zausig; Miriam Klauss; Reinhard Singer; Jens Werner; Götz Martin Richter; Hans-Ulrich Kauczor; Lars Grenacher
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

4.  Three-dimensional models of arteries constructed using multidetector-row CT images to perform pancreatoduodenectomy safely following dissection of the inferior pancreaticoduodenal artery.

Authors:  Akihiko Horiguchi; S Ishihara; M Ito; Y Asano; T Yamamoto; S Miyakawa
Journal:  J Hepatobiliary Pancreat Sci       Date:  2010-02-09       Impact factor: 7.027

5.  En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma.

Authors:  Hirohisa Kitagawa; Hidehiro Tajima; Hisatoshi Nakagawara; Isamu Makino; Tomoharu Miyashita; Masatoshi Shoji; Shinichi Nakanuma; Norihiro Hayashi; Hiroyuki Takamura; Tetsuo Ohta; Hiroshi Ohtake
Journal:  Mol Clin Oncol       Date:  2014-02-27

6.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

Review 7.  An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.

Authors:  Alexander Stojadinovic; Ari Brooks; Axel Hoos; David P Jaques; Kevin C Conlon; Murray F Brennan
Journal:  J Am Coll Surg       Date:  2003-06       Impact factor: 6.113

8.  Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.

Authors:  M Wagner; C Redaelli; M Lietz; C A Seiler; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2004-05       Impact factor: 6.939

9.  Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion.

Authors:  M Kayahara; T Nagakawa; K Ueno; T Ohta; Y Tsukioka; I Miyazaki
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

10.  The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials.

Authors:  J Gaedcke; B Gunawan; M Grade; R Szöke; T Liersch; H Becker; B M Ghadimi
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.